SK Biopharmaceuticals Co., Ltd. (326030.KS) Earnings - Next Date and History
SK Biopharmaceuticals Co., Ltd. (326030.KS) will report earnings on November 5, 2026.
Next earnings
- Date
- (Estimate)
- EPS (Estimate)
- ₩594.78
- Revenue (Estimate)
- ₩249.5B
Earnings history
| Date | EPS (Estimate) | EPS (Actual) | Revenue (Estimate) | Revenue (Actual) |
|---|---|---|---|---|
| ₩563.67 | ₩581.55 | ₩233.8B | ₩247.4B | |
| ₩481.02 | ₩1,312 | ₩214.5B | ₩227.9B | |
| ₩434.02 | ₩1,695 | ₩193.8B | ₩194.4B | |
| ₩342.46 | ₩947 | ₩202.5B | ₩191.7B | |
| ₩390.33 | ₩420 | ₩183.9B | ₩176.3B | |
| ₩355.53 | ₩298 | ₩157.1B | ₩144.4B | |
| ₩236.84 | ₩2,422 | ₩158.0B | ₩163.0B | |
| ₩184.9 | ₩123 | ₩131.5B | ₩136.6B | |
| ₩87.9 | ₩359 | ₩118.9B | ₩134.0B | |
| ₩46.28 | ₩164 | ₩103.0B | ₩114.0B | |
| ₩184 | ₩86.32 | ₩107.2B | ₩126.8B | |
| -₩264.74 | -₩235 | ₩92.7B | ₩90.3B |